clinical trial · NCT05227924
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Dedienne Sante S.A.S.·—·recruiting·n = 747
Degenerative Hip Joint DiseasePost-traumatic OsteoarthritisHip ArthritisFemoral Neck FracturesAvascular Necrosis of the Femoral HeadFailure of Prosthetic Joint ImplantTotal hip arthroplasty (primary or revision)
brief summary
The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.
started
Sep 21, 2021
primary completion
Sep 1, 2034
completion
Sep 1, 2034
last updated
Aug 27, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol